Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuraxis (NRXS) Operating Expenses (2022 - 2025)

Neuraxis (NRXS) has disclosed Operating Expenses for 4 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 24.86% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.5 million through Dec 2025, down 2.06% year-over-year, with the annual reading at $8.1 million for FY2025, 0.89% up from the prior year.
  • Operating Expenses hit $1.5 million in Q4 2025 for Neuraxis, down from $1.9 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $3.4 million in Q3 2023 to a low of $37231.0 in Q4 2023.
  • Historically, Operating Expenses has averaged $1.9 million across 4 years, with a median of $1.8 million in 2024.
  • Biggest five-year swings in Operating Expenses: crashed 97.45% in 2023 and later surged 5166.98% in 2024.
  • Year by year, Operating Expenses stood at $1.5 million in 2022, then plummeted by 97.45% to $37231.0 in 2023, then soared by 5166.98% to $2.0 million in 2024, then dropped by 24.86% to $1.5 million in 2025.
  • Business Quant data shows Operating Expenses for NRXS at $1.5 million in Q4 2025, $1.9 million in Q3 2025, and $2.3 million in Q2 2025.